Why the study?
The effect of baseline diastolic dysfunction on outcomes of patients with post-TAVR aortic insufficiency had not been studied.
Observational (n=939)
No
Hazard Ratio: 2.38 (95% CI 1.28–4.42)
p-value: p=<0.01
May warrant closer post-TAVR surveillance in diastolic dysfunction; leaves open whether mitigating mild regurgitation improves survival.
OBJECTIVES: We sought to examine whether baseline diastolic dysfunction (DD) is associated with increased mortality in patients who develop aortic insufficiency (AI) after transcatheter aortic valve replacement (TAVR). BACKGROUND: Significant post-TAVR AI is associated with increased mortality, likely secondary to adverse hemodynamics secondary to volume overload and decreased LV compliance from chronic pressure overload. However, the effect of baseline DD on outcomes of patients with post-TAVR AI has not been studied. METHODS: A total of 195 patients undergoing TAVR were included in the study. Patients with moderate-to-severe mitral stenosis, prior mitral valve replacement or atrial fibrillation were excluded. DD was classified at baseline by a 2-step approach as recommended by the American Society of Echocardiography while AI was evaluated 30 days post-TAVR. Follow up data up to 2 years post-TAVR was used in survival analysis. RESULTS: Patients with severe baseline DD who developed ≥mild post-TAVR AI had increased mortality compared to all other patients (HR = 3.89, CI: 1.76-8.6, P = 0.001), which remained significant after adjusting for post-TAVR AI, pre-TAVR AI, baseline mitral regurgitation, ejection fraction, pulmonary artery pressure, creatinine clearance and history of stroke. CONCLUSIONS: Even mild post-TAVR AI may have a negative impact on outcomes of patients with underlying severe DD.
No takes yet. Share an insight, caveat, or question.
Kampaktsis et al. (2016) conducted an observational in Severe aortic stenosis undergoing TAVR (n=939). Elevated preprocedural left ventricular filling pressure (baseline E/A > 1) combined with mild paravalvular regurgitation vs. Baseline E/A ≤ 1 with none/trace paravalvular regurgitation was evaluated on Cardiovascular death within 5 years after TAVR (adjusted HR 2.38, 95% CI 1.28-4.42, p=<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: